Park Medi World Limited (NSE:PARKHOSPS)

India · Delayed Price · Currency is INR

217.70

-4.70 (-2.11%)

At close: Oct 22, 2026

Market Cap	94.03B
Revenue (ttm)	17.56B +21.4%
Net Income	2.83B +34.9%
EPS	7.23 +28.9%
Shares Out	431.93M
PE Ratio	30.12
Forward PE	23.76
Dividend	n/a
Ex-Dividend Date	n/a

Volume	781,513
Open	222.40
Previous Close	222.40
Day's Range	213.55 - 222.40
52-Week Range	138.10 - 305.00
Beta	n/a
Analysts	Strong Buy
Price Target	362.50 (+66.51%)
Est. Earnings	Nov 3, 2026

About Park Medi World

Park Medi World Limited operates a network of hospitals. The company provides cardiac sciences, neurosciences - brain and spine, plastic and cosmetic surgery, general and laparoscopic surgery, renal sciences and kidney transplant, bone, orthopaedics, joint replacement and sports medicine, gastroenterology and surgical gastroenterology, cancer care, bone marrow transplant, iMARS / robot-assisted surgery. It also offers bariatric surgery, anaesthesiology, critical care, chest and respiratory diseases, dental care, dermatology, endocrinology, paed... [Read more]

Industry Medical Care Facilities

Sector Healthcare

Founded 2005

Employees 6,423

Stock Exchange National Stock Exchange of India

Ticker Symbol PARKHOSPS

Full Company Profile

Financial Performance

In fiscal year 2026, Park Medi World's revenue was 16.79 billion, an increase of 20.51% compared to the previous year's 13.94 billion. Earnings were 2.58 billion, an increase of 28.01%.

Financial Statements

Analyst Summary

According to 2 analysts, the average rating for PARKHOSPS stock is "Strong Buy." The 12-month stock price target is ₹362.50, which is an increase of 66.51% from the latest price.

Price Target

₹362.50

(66.51% upside)

Analyst Consensus: Strong Buy

Stock Forecasts